The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
Extensior Launch Cuts Ozempic Cost By 15%
Original Article by Tamar Kahn | Business Day | 24 July 2026
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
Image | Marc Bruxelle | 123rf/219368006
More Posts
Older Adults With HIV Set To Double By 2040
Older adults with HIV will nearly double by 2040. South Africa faces one of the sharpest rises, straining health systems.
Read more...
Rosebank Health Village Expands Growthpoint Portfolio
Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.
Read more...
Global HIV Funding Cuts Put AIDS Progress At Risk
Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.
Read more...